Translating Innovation into Therapies

Aug 15, 2017

Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.

Astia CEO, Sharon Vosmek, keynotes the ON Helix 2017 conference; speaks on Astia Angels investment thesis: <strong><em>"Putting the C in Science: Commercialisation, Community and Capital"</em></strong>